(VIANEWS) – Sensata Technologies Holding N.V. Ordinary Shares (ST), Saia (SAIA), Benchmark Electronics (BHE) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Sensata Technologies Holding N.V. Ordinary Shares (ST)

12.9% sales growth and 8.56% return on equity

Sensata Technologies Holding plc designs, produces, and markets sensors, sensor-based products, controls and other products throughout the Americas and Europe.

Sensata Technologies Holding N.V. Ordinary Shares’s sales growth this year is expected to be 6.4% and 7.1% for next year.

Year-on-year quarterly revenue growth grew by 2.8%, now sitting on 3.88B for the twelve trailing months.

Volume

Today’s last reported volume for Sensata Technologies Holding N.V. Ordinary Shares is 1651400 which is 45.86% above its average volume of 1132130.

Sensata Technologies Holding N.V. Ordinary Shares’s sales growth for the next quarter is 12.9%. The company’s growth estimates for the current quarter and the next is 19.5% and 32.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.56%.

Volatility

Sensata Technologies Holding N.V. Ordinary Shares’s last day, last week, and last month’s current intraday variation average was 0.38%, 1.74%, and 2.11%, respectively.

Sensata Technologies Holding N.V. Ordinary Shares’s highest amplitude of average volatility was 1.69% (day), 2.30% (last week), and 2.79% (last month), respectively.

Sensata Technologies Holding N.V. Ordinary Shares’s Stock Yearly Top and Bottom Value

Sensata Technologies Holding N.V. Ordinary Shares’s stock is valued at $45.03 at 11:22 EST, way under its 52-week high of $65.58 and way higher than its 52-week low of $38.31.

Sensata Technologies Holding N.V. Ordinary Shares’s Moving Average

Sensata Technologies Holding N.V. Ordinary Shares’s value is above its 50-day moving average of $43.68 and way below its 200-day moving average of $52.00.

2. Saia (SAIA)

10.4% sales growth and 27.74% return on equity

Saia, Inc., via its subsidiaries, is a North American transportation company.

Saia’s sales growth this year is anticipated to be 22.7% and 3.1% for next year.

Year-on-year quarterly revenue growth grew by 30.5%, now sitting on 2.64B for the twelve trailing months.

Volume

Today’s last reported volume for Saia is 443069 which is 10.07% below its average volume of 492701.

Saia’s sales growth for the next quarter is 10.4%. The company’s growth estimates for the current quarter and the next is 21.3% and 8.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.74%.

Volatility

Saia’s last day, last week, and last month’s current intraday variation average was 1.63%, 3.62%, and 2.48%, respectively.

Saia’s highest amplitude of average volatility was 3.94% (day), 6.87% (last week), and 5.40% (last month), respectively.

Saia’s Stock Yearly Top and Bottom Value

Saia’s stock is valued at $237.85 at 11:22 EST, way under its 52-week high of $365.50 and way higher than its 52-week low of $168.03.

Saia’s Moving Average

Saia’s worth is way above its 50-day moving average of $196.88 and under its 200-day moving average of $258.18.

3. Benchmark Electronics (BHE)

10.2% sales growth and 4.98% return on equity

Benchmark Electronics, Inc., along with its affiliates, offers product design, engineering solutions, technology solutions, advanced manufacturing services, and other services throughout the Americas, Asia, Europe, and Africa.

Benchmark Electronics’s sales growth this year is anticipated to be 13.3% and 4.6% for next year.

Year-on-year quarterly revenue growth grew by 33.7%, now sitting on 2.57B for the twelve trailing months.

Volume

Today’s last reported volume for Benchmark Electronics is 141090 which is 13.85% below its average volume of 163775.

Benchmark Electronics’s sales growth is a negative 0% for the present quarter and 10.2% for the next. The company’s growth estimates for the current quarter and the next is 51.9% and 15.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.98%.

Volatility

Benchmark Electronics’s last day, last week, and last month’s current intraday variation average was 1.01%, 1.29%, and 1.46%, respectively.

Benchmark Electronics’s highest amplitude of average volatility was 1.97% (day), 3.25% (last week), and 2.81% (last month), respectively.

Benchmark Electronics’s Stock Yearly Top and Bottom Value

Benchmark Electronics’s stock is valued at $26.73 at 11:23 EST, under its 52-week high of $28.29 and way above its 52-week low of $21.11.

Benchmark Electronics’s Moving Average

Benchmark Electronics’s worth is way higher than its 50-day moving average of $24.00 and higher than its 200-day moving average of $24.86.

4. Pfizer (PFE)

8.9% sales growth and 31.87% return on equity

Pfizer Inc. designs, manufactures and markets healthcare products around the world.

Pfizer’s sales growth this year is anticipated to be 28.8% and a negative 25.2% for next year.

Year-on-year quarterly revenue growth grew by 106.8%, now sitting on 81.29B for the twelve trailing months.

Volume

Today’s last reported volume for Pfizer is 20567200 which is 0.94% below its average volume of 20763000.

Pfizer’s sales growth for the next quarter is 8.9%. The company’s growth estimates for the present quarter and the next is 89.7% and 41%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.87%.

Volatility

Pfizer’s last day, last week, and last month’s current intraday variation average was 3.77%, 2.95%, and 1.18%, respectively.

Pfizer’s highest amplitude of average volatility was 3.79% (day), 2.91% (last week), and 2.22% (last month), respectively.

Pfizer’s Stock Yearly Top and Bottom Value

Pfizer’s stock is valued at $50.08 at 11:23 EST, way under its 52-week high of $61.71 and way above its 52-week low of $38.82.

Pfizer’s Moving Average

Pfizer’s value is below its 50-day moving average of $50.59 and below its 200-day moving average of $50.24.

Previous days news about Pfizer(PFE)

  • According to CNBC on Monday, 8 August, "Global Blood Therapeutics (GBTThe maker of blood disorder treatments will be bought by Pfizer (PFE) for $5.4 billion, or $68.50 per share in cash. "
  • Pfizer confirms to acquire global blood therapeutics for $5.4 billion in deal that gives it access to sickle-cell disease treatment. According to MarketWatch on Monday, 8 August, "The acquisition "complements and further enhances Pfizer’s more than 30-year heritage in rare hematology and reinforces the company’s commitment to SCD by bringing expertise and a leading portfolio and pipeline with the potential to address the full spectrum of critical needs in this underserved community," Pfizer said in a statement. "
  • According to MarketWatch on Monday, 8 August, "The U.S.-listed shares of Germany-based BioNTech SE sank 8.2% in premarket trading Monday, after the biotechnology company and Pfizer Inc. partner in developing a COVID-19 vaccine reported second-quarter profit and revenue that fell below expectations but affirmed its full-year COVID-19 revenue outlook. ", "BioNTech’s stock has rallied 34.5% over the past three months through Friday while Pfizer shares have gained 0.5% and the S&P 500 has tacked on 0.5%."

5. Hawkins (HWKN)

8.8% sales growth and 18.25% return on equity

Hawkins, Inc. manufactures, distributes, blends, and markets chemicals in the United States as well as internationally.

Hawkins’s sales growth this year is expected to be 24.1% and a negative 1.1% for next year.

Year-on-year quarterly revenue growth grew by 30.9%, now sitting on 714.54M for the twelve trailing months.

Volume

Today’s last reported volume for Hawkins is 56723 which is 1.68% below its average volume of 57695.

Hawkins’s sales growth for the next quarter is 8.8%. The company’s growth estimates for the present quarter and the next is a negative 0% and negative -15.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.25%.

Volatility

Hawkins’s last day, last week, and last month’s current intraday variation average was 2.62%, 2.23%, and 1.45%, respectively.

Hawkins’s highest amplitude of average volatility was 3.17% (day), 3.09% (last week), and 2.69% (last month), respectively.

Hawkins’s Stock Yearly Top and Bottom Value

Hawkins’s stock is valued at $39.75 at 11:23 EST, way below its 52-week high of $48.12 and way above its 52-week low of $32.44.

Hawkins’s Moving Average

Hawkins’s value is way higher than its 50-day moving average of $35.79 and higher than its 200-day moving average of $38.69.

6. IDEXX Laboratories (IDXX)

6.3% sales growth and 109.37% return on equity

IDEXX Laboratories, Inc., along with its subsidiaries, creates, manufactures, distributes, products and services primarily to the companion animal veterinary, poultry, milk, and water testing markets around the world.

IDEXX Laboratories’s sales growth this year is expected to be 6.4% and 10% for next year.

Year-on-year quarterly revenue growth grew by 7.6%, now sitting on 3.27B for the twelve trailing months.

Volume

Today’s last reported volume for IDEXX Laboratories is 434471 which is 29.63% below its average volume of 617441.

IDEXX Laboratories’s sales growth for the next quarter is 6.3%. The company’s growth estimates for the present quarter and the next is a negative 29.9% and 10.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 109.37%.

Volatility

IDEXX Laboratories’s last day, last week, and last month’s current intraday variation average was 0.06%, 1.75%, and 1.83%, respectively.

IDEXX Laboratories’s highest amplitude of average volatility was 3.34% (day), 3.23% (last week), and 3.40% (last month), respectively.

IDEXX Laboratories’s Stock Yearly Top and Bottom Value

IDEXX Laboratories’s stock is valued at $396.68 at 11:23 EST, way below its 52-week high of $695.18 and way higher than its 52-week low of $318.50.

IDEXX Laboratories’s Moving Average

IDEXX Laboratories’s value is above its 50-day moving average of $370.23 and way below its 200-day moving average of $497.63.

LEAVE A REPLY

Please enter your comment!
Please enter your name here